Osstem Implant Co., Ltd. (KOSDAQ:A048260) announced a private placement of series 7 unregistered non-guaranteed private convertible bonds for gross proceeds of KRW 50,000,000,000 on October 27, 2020. The transaction will include participation from Kb-Brain Kosdaq Scale-Up New Technology Business Investment Fund for KRW 8,000,000,000, Shinhan Investment Corp., Investment Arm for KRW 5,000,000,000, Hanyang Securities Co., Ltd., Investment Arm for KRW 4,000,000,000, Mirae Asset Capital Co,Ltd., Investment Arm for KRW 3,000,000,000, IBKC-EQP Innovative Technology Fund, a fund managed by Korea Investment Private Equity for KRW 2,000,000,000, Ibest Investment Company Ltd. for KRW 3,000,000,000, BNK Securities Co., Ltd., Investment Arm for KRW 1,000,000,000, Ace Investment & Finance Co., Ltd. for KRW 500,000,000, and SP Mezzanine Hedge Fund 6, SP KOSDAQ Venture Hedge Fund 2, Rhinos Mezzanine Private Investment Trust 6 and Anda H KOSDAQ Venture Hedge Fund A for KRW 2,000,000,000 each, Rhinos KOSDAQ Venture Public Offering Stock Private Investment Trust 3 and Solon New Technology Fund 1 for KRW 3,000,000,000 each, Rhinos Smart Korea Mezzanine Private Investment Trust for KRW 1,500,000,000, NH Absolute Return Hedge Fund 1, Rhinos Mezzanine Private Investment Trust 5, C Square Mezzanine Challenge and gratitude Hedge Fund 1 and Anda H KOSDAQ Venture Hedge Fund 1 for KRW 1,000,000,000 each, and Ace Susung New Technology Fund 10 and Rhinos KOSDAQ Venture Mezzanine Private Investment Trust 2 for 500,000,000 each. The bonds will be issued at par and do not carry any coupon. The bonds have yield to maturity of 0% and would mature on October 29, 2025. The bonds will be fully convertible into 1,290,788 shares representing 9.04% stake at a fixed conversion price of KRW 38,736 from October 29, 2022 to September 29, 2025. The subscription and the payment dates are October 29, 2020. The transaction has been approved by the board of directors of the company.